Skip to main content
SP5007,674.37+0.43%DOW53,277.01+0.98%NASDAQ26,180.46+0.43%BTC$77,812.00+5.53%ETH$2,513.75+7.22%GOLD$4,661.60+1.97%OIL$86.64-0.22%
Smart Investors Daily
Sign InSign Up Free
HT

NASDAQ · HTGM

HTG Molecular Diagnostics, Inc.

Healthcare · Medical - Diagnostics & Research

$0.48

Up+$0.00 (+0.00%)

Updated Aug 22, 2026, 4:49 PM

SID Score

—

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
1.06M
P/E ratio
-0
Dividend yield
0.00%
52-week range
— – —
Volume
725.43K
Avg. volume
258.7K

Price performance

HTGM price history

1M range · 0 trading sessions · Daily adjusted prices

HTGM does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest HTGM news

The latest Smart Investors Daily articles mentioning HTGM.

Stock researchCompany · Overview

HTGM research

Overview

Company profile and research snapshot.

Company profile

HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables comprising assay kits; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq DLBCL cell of origin assay; HTG EdgeSeq Oncology Biomarker Panel; HTG EdgeSeq ALKPlus assay EU; HTG EdgeSeq Pan B-Cell Lymphoma Panel; HTG immune response panel; and HTG mouse mRNA tumor response panel. The company distributes its instruments and consumables directly in the United States and Europe; and through distributors in parts of Europe and internationally. It serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. HTG Molecular Diagnostics, Inc. has a governing agreement with QIAGEN Manchester Limited. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$0.17
Implied upside
—
Analysts
—
HTGM recent ratings
DateFirmRatingTarget
Apr 19, 2023HC Wainwright & Co.Buy—
Apr 3, 2023HC Wainwright & Co.Buy—
Aug 15, 2022HC Wainwright & Co.Buy—
May 16, 2022HC Wainwright & Co.Buy—
Mar 31, 2022HC Wainwright & Co.Buy—
Open full forecast

News briefing

No generated briefing is available yet.

Benzinga · May 17, 2023

Why Sunrise New Energy Shares Are Trading Higher By 35%; Here Are 20 Stocks Moving Premarket

Gainers WeTrade Group, Inc. (NASDAQ: WETG) shares surged 93.7% to $0.0736 in pre-market trading after dropping around 15% on Tuesday. WeTrade Group recently received a notice of noncompliance from Nasdaq because it failed to timely file its 2022 annual report on form 10-K with the SEC. Smart for Life, Inc. (NASDAQ: SMFL) shares rose 47.4% to $3.42 in pre-market trading. Smart For Life recently announced a $900,000 registered direct offering priced at-the-market under Nasdaq rules. JE Cleantech Holdings Limited (NASDAQ: JCSE) shares gained 37.4% to $0.7163 in pre-market trading after dropping 13% on Tuesday. Sunrise New Energy Co., Ltd. (NASDAQ: EPOW) shares gained 35.2% to $2.61 in pre-market trading after the company reported a sharp rise in sales for the fiscal year ended Dec. 31, 2022. Ascent Solar Technologies, Inc. (NASDAQ: ASTI) rose 21.1% to $0.23 in pre-market trading after dropping over 8% on Tuesday. Ascent Solar Technologies recently ...

GlobeNewswire Inc. · May 16, 2023

HTG Highlights the Advantages of Its Drug Discovery Engine

TUCSON, Ariz., May 16, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools and drug discovery company, today reported achievement of another technical milestone in its drug discovery business.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By